Andrea Goren - 15 Jan 2022 Form 4 Insider Report for INVO Bioscience, Inc. (IVF)

Role: Chief Financial Officer
Signature: /s/ Andrea Goren
Issuer symbol: IVF
Transactions as of: 15 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 18 Jan 2022, 20:26:01 UTC
Previous filing: 07 Oct 2021
Next filing: 03 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INVO	Common Stock	Award	$0	+5,361	+43%	$0.000000	17,861	15 Jan 2022	Direct
holding	INVO	Common Stock						5,000	15 Jan 2022	Direct	F1
holding	INVO	Common Stock						76,383	15 Jan 2022	Via Andax LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INVO	Stock Option	Award	$0	+15,197		$0.000000	15,197	15 Jan 2022	Common Stock	15,197	$3.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units which vest in substantially equal monthly increments over a period of 12 months from the date of grant of July 1, 2021
F2	The stock option vests in monthly increments over a period of three years from the date of grant.